Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
$361K Sell
4,516
-4,571
-50% -$341K ﹤0.01% 420
2018
Q2
$612K Sell
9,087
-575
-6% -$41.8K 0.01% 334
2018
Q1
$743K Buy
9,662
+4,476
+86% +$331K 0.01% 315
2017
Q4
$354K Buy
5,186
+68
+1% +$4.51K ﹤0.01% 410
2017
Q3
$321K Buy
5,118
+300
+6% +$17.9K ﹤0.01% 407
2017
Q2
$267K Buy
4,818
+431
+10% +$22.4K ﹤0.01% 397
2017
Q1
$220K Buy
4,387
+356
+9% +$17.4K ﹤0.01% 404
2016
Q4
$200K Sell
4,031
-217
-5% -$11K ﹤0.01% 379
2016
Q3
$223K Buy
+4,248
New +$208K 0.01% 348
2015
Q4
Sell
-3,097
Closed -$102K 1099
2015
Q3
$102K Buy
3,097
+1,521
+97% +$51.2K ﹤0.01% 406
2015
Q2
$58K Buy
1,576
+562
+55% +$20.4K ﹤0.01% 493
2015
Q1
$36K Sell
1,014
-272
-21% -$9.59K ﹤0.01% 502
2014
Q4
$49K Sell
1,286
-2,402
-65% -$87.9K ﹤0.01% 484
2014
Q3
$131K Buy
3,688
+544
+17% +$20.2K 0.01% 235
2014
Q2
$123K Buy
3,144
+450
+17% +$16.8K 0.01% 182
2014
Q1
$100K Buy
+2,694
New +$98.2K 0.01% 130

Other funds holding XYL

Wealthfront's XYL Position: Q3 2018 in Review

Wealthfront reduced its Xylem (XYL) stake by 50% in Q3 2018, selling an estimated $341K and leaving 4,516 shares worth $361K. The position accounts for ﹤0.01% of the portfolio, ranked #420.

Wealthfront first reported a position in XYL in Q1 2014 and has held it in 16 quarters since. The position peaked at $743K in Q1 2018. 667 funds tracked by Wall St. Rank hold XYL as of Q3 2018.

  • Wealthfront held 4,516 shares of Xylem worth $361K as of Q3 2018.
  • Wealthfront sold 4,571 Xylem shares in Q3 2018, an estimated $341K.
  • Xylem made up ﹤0.01% of Wealthfront's portfolio in Q3 2018, its #420 holding.
  • Wealthfront first reported a position in Xylem in Q1 2014 and has held it in 16 quarters since.
  • Wealthfront's Xylem position peaked at $743K in Q1 2018.
  • 667 funds tracked by Wall St. Rank held Xylem as of Q3 2018.

Based on Wealthfront's 13F filing for Q3 2018, filed 13 Nov 2018.